Western equine encephalitis virus (WEEV)

Western equine encephalitis virus (WEEV) is an enveloped, single-stranded, positive-sense RNA virus of the genus Alphavirus and family Togaviridae[4][5][7][9]. It is transmitted primarily by mosquitoes (notably Culex and Culiseta in North America) and causes Western equine encephalitis, a zoonotic viral infection affecting the brain and spinal cord of humans and horses[5][9]. WEEV is a recombinant virus, with genetic contributions from both ancestral Sindbis-like and Eastern equine encephalitis virus-like viruses, and is endemic mainly in the Americas[5]. Its envelope consists of E1 and E2 glycoproteins and a nucleocapsid, with host-derived lipid bilayer[1]. While the disease is uncommon and most human infections are asymptomatic, WEE can result in severe neurological disease, particularly in children and horses. WEEV is not itself a druggable molecular target (like a protein, receptor, or enzyme), but rather a pathogenic organism. There is no human vaccine or licensed therapeutic drug for WEEV infection[5]. Notes: - WEEV is a virus, not a single molecular target or receptor. - This means it does not fit standard drug target categories such as "receptor," "enzyme," or "ion channel." - If your intent was to retrieve information about a specific viral protein or a molecular target within WEEV (e.g., E1 or E2 envelope glycoproteins, capsid protein), please specify which protein for structured target information. Is_incorrect is true, because "Western equine encephalomyelitis virus" refers to a viral pathogen, not to a canonical therapeutic target molecule as defined in drug discovery (receptor, enzyme, etc.)[1][5].

Other names

Western equine encephalitisWEE virus